Provided by Tiger Fintech (Singapore) Pte. Ltd.

Achieve Life Sciences, Inc.

2.36
-0.0400-1.67%
Volume:262.01K
Turnover:634.21K
Market Cap:81.86M
PE:-1.90
High:2.48
Open:2.39
Low:2.36
Close:2.40
Loading ...
Sep 13, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Sep 12, 2019

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Aug 15, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Aug 15, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Aug 08, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Aug 08, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Aug 05, 2019

Correspondence

[Cover]Correspondence
Aug 02, 2019

[Amend]Public Prospectus

[Amend] General form for registration of securities under the Securities Act of 1933
Jul 25, 2019

Public Prospectus

General form for registration of securities under the Securities Act of 1933
Jun 13, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 13, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 13, 2019

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Jun 11, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Jun 07, 2019

Statement Of Changes In Beneficial Ownership

Initial statement of beneficial ownership of securities
Jun 07, 2019

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Jun 07, 2019

Major Issues Report

Current report, items 1.01 and 9.01
Jun 03, 2019

Major Issues Report

Current report, items 1.01, 3.02, and 9.01
May 15, 2019

Major Issues Report

Current report, items 2.02, 5.07, and 9.01
May 15, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Feb 07, 2019

Correspondence

[Cover]Correspondence